Completed PHASE4 INTERVENTIONAL 1-arm NCT01462500

Pharmacokinetics of Miltefosine in Children and Adults (PK)

Pharmacokinetics of Miltefosine in Children and Adults: Implications for the Treatment of Cutaneous Leishmaniasis in Colombia.

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions Cutaneous Leishmaniasis

Interventions Miltefosine

Updated 7 times since 2017 Last updated: Aug 18, 2016 Started: Oct 31, 2011 Primary completion: May 31, 2014 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Cutaneous Leishmaniasis and is currently completed. Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Nov 2025 — Present [monthly]

Completed PHASE4
Sep 2025 — Nov 2025 [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Centro Internacional de Entrenamiento e Investigaciones Médicas

Data source: Centro Internacional de Entrenamiento e Investigaciones Médicas

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cali, Colombia